Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
VectorBuilder is a global leader in gene delivery technologies, offering a comprehensive suite of solutions for researchers and pharmaceutical companies. Their services range from vector design and cloning to virus packaging, library construction, stable cell line generation, and GMP manufacturing for applications spanning basic research to clinical trials. With a strong emphasis on innovation and customer service, VectorBuilder aims to accelerate advancements in life sciences and gene therapy.
Serves as the central hub for North American operations, including advanced R&D, GMP manufacturing, customer support, and strategic business development for the region.
Features state-of-the-art laboratories, GMP-compliant cleanrooms for vector production, and advanced research equipment dedicated to gene delivery solutions.
A dynamic and innovative environment fostering collaboration among scientists, researchers, and technical staff, driven by a commitment to scientific excellence and customer success in gene delivery.
Crucial for VectorBuilder's global strategy, providing cutting-edge gene delivery services to the North American academic, biotech, and pharmaceutical sectors, and contributing to local biotech ecosystem growth.
VectorBuilder maintains a significant global footprint with headquarters in North America (Chicago, USA), Europe (Hennigsdorf, Germany), and Asia (Guangzhou, China), along with regional offices in Japan, the UK, and Australia. This network supports worldwide research, development, manufacturing, and customer service for its comprehensive suite of gene delivery solutions, including vector design, virus packaging, library construction, stable cell line generation, and GMP services for preclinical to clinical applications.
2770 S. Wasson St.
Chicago
IL
USA
Address: Neuendorfstrasse 24a, 16761 Hennigsdorf, Germany
To provide localized support and rapid service delivery to the European research community, strengthening VectorBuilder's presence in a key biotech market.
Address: Building D, 3 Ju Cheng Rd, Guangzhou International Bio Island, Guangzhou, 510005, China
To cater to the rapidly growing Asia-Pacific market, leverage local talent and manufacturing efficiencies, and drive R&D in advanced gene delivery technologies.
Address: Yokohama Bio Industry Center, 1-6 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan
To provide specialized support and foster collaborations within Japan's advanced biotechnology and pharmaceutical research landscape.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, VectorBuilder' leadership includes:
VectorBuilder has been backed by several prominent investors over the years, including:
In early 2024, VectorBuilder significantly strengthened its leadership by appointing a new Chief Scientific Officer and a new Chief Operating Officer, signaling a strategic push towards enhanced R&D capabilities and operational excellence.
Discover the tools VectorBuilder uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
VectorBuilder Inc. commonly utilizes the email format combining the first initial and last name for its employees (e.g., jdoe@vectorbuilder.com). Other formats may exist but this is the most frequently observed pattern.
[first_initial][last]@vectorbuilder.com
Format
bsmith@vectorbuilder.com
Example
80%
Success rate
PR Newswire • February 13, 2024
VectorBuilder announced the appointment of Dr. Miles Wang as its new Chief Scientific Officer (CSO). Dr. Wang will lead the company's global research and development strategies, focusing on innovating new gene delivery technologies....more
Business Wire • July 10, 2023
VectorBuilder announced its plans to build a new state-of-the-art R&D and manufacturing facility in Singapore. This expansion aims to enhance its gene delivery capabilities and better serve the burgeoning Asia-Pacific biotech market....more
GEN Edge • March 29, 2023
VectorBuilder acquired a novel minibioprinting technology from Fabrigen. This strategic acquisition is set to revolutionize the construction of DNA vectors, significantly improving efficiency and precision for gene therapy and research applications....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including VectorBuilder, are just a search away.